Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer’s Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD (S26.007)
Autor: | John Hey, Susan Abushakra, Kaj Blennow, Philip Scheltens, Jakub Hort, Katerina Sheardova, Niels Prins, Sterre Rutgers, Paul Dautzenberg, Ladislav Pazdera, Patrick Kesslak, Rosalind Mandelbaum, Aidan Power, Martin Tolar |
---|---|
Rok vydání: | 2023 |
Zdroj: | Tuesday, April 25. |
Databáze: | OpenAIRE |
Externí odkaz: |